<unk>  (marketed under the brand name Deracyn) is a benzodiazepine derivative, and more specifically, a triazolobenzodiazepine (TBZD). It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties.<unk>  was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed.<unk>  was never FDA approved and never made available to the public market.
Adinazolam
Ketazolam
Midazolam 
Climazolam
Triazolam
Cloxazolam
Estazolam
Diazepam 